Cost-effectiveness of treating patients with advanced progressive pancreatic neuroendocrine tumors with everolimus versus sunitinib in the United States.
Maruit Chulikavit
Consultant or Advisory Role - Novartis
Roman Casciano
Consultant or Advisory Role - Novartis
Allison Perrin
Consultant or Advisory Role - Novartis
Zhimei Liu
Stock Ownership - Novartis
Xufang Wang
Stock Ownership - Novartis
Joseph Babigumira
Consultant or Advisory Role - Novartis
Kris Grzegorzewski
Stock Ownership - Novartis
Louis P Garrison
Consultant or Advisory Role - Novartis